However, an increase to 6-15 mM relaxes vascular smooth muscle. This relaxation is well known as K ϩ -induced relaxation, which is prominent in the vascular smooth muscles of resistant arteries and considered as an important regulator of resistant artery contractility (22, 25, 32) . Compared with resistant arteries, K ϩ -induced relaxations are relatively small or negligible in large arteries such as the aorta. The following mechanism of K ϩ -induced relaxation has been determined (10, 11, 25, 33 
]i concentration dependently. In current-clamped HUVEC, increasing [K ϩ ]o from 6 to 12 mM depolarized membrane potential from Ϫ32.8 Ϯ 2.7 to Ϫ8.6 Ϯ 4.9 mV (n ϭ 8). In voltage-clamped HUVEC, depolarizing the holding potential from Ϫ50 to Ϫ25 mV decreased [Ca 2ϩ ]i significantly from 0.95 Ϯ 0.03 to 0.88 Ϯ 0.03 M (n ϭ 11, P Ͻ 0.01) and further decreased [Ca 2ϩ ]i to 0.47 Ϯ 0.04 M by depolarizing the holding potential from Ϫ25 to 0 mV (n ϭ 11, P Ͻ 0.001). Tetraethylammonium (1 mM) inhibited EDR and the ATPinduced [Ca 2ϩ ]i increase in voltage-clamped MAEC. The intermediate-conductance Ca 2ϩ -activated K ϩ channel openers 1-ethyl-2-benzimidazolinone, chlorozoxazone, and zoxazolamine reversed the K ϩ -induced inhibition of EDR and increase in [Ca 2ϩ ]i. The K ϩ -induced inhibition of EDR and increase in [Ca 2ϩ ]i was abolished by the Na ϩ -K ϩ pump inhibitor ouabain (10 M). These results indicate that an increase of [K ϩ ]o in the physiological range (6-12 mM) inhibits [Ca 2ϩ ]i increase in endothelial cells and diminishes EDR by depolarizing the membrane potential, decreasing K ϩ efflux, and activating the Na ϩ -K ϩ pump, thereby modulating the release of endothelium-derived vasoactive factors from endothelial cells and vasomotor tone. (5, 7, 29) . This activation, in turn, induces an efflux of intracellular K ϩ . In brain tissues, activated neuronal cells release K ϩ , which enters surrounding astrocytes. As a result, K ϩ is further released from activated neuronal cells and astrocytes (28, 32, 39 However, an increase to 6-15 mM relaxes vascular smooth muscle. This relaxation is well known as K ϩ -induced relaxation, which is prominent in the vascular smooth muscles of resistant arteries and considered as an important regulator of resistant artery contractility (22, 25, 32) . Compared with resistant arteries, K ϩ -induced relaxations are relatively small or negligible in large arteries such as the aorta. The following mechanism of K ϩ -induced relaxation has been determined (10, 11, 25, 33 
METHODS

Contraction Measurement on Isolated Aortic Rings
Five-to 6-mo-old mice of either gender were anesthetized by injection of pentobarbital sodium (50 mg/kg body wt ip) and killed by cervical dislocation. The thoracic aorta was dissected out and cut into ϳ3.0-mm rings. A homemade myograph was used to record mechanical responses from the aortic ring segments (37) . Each aortic ring was threaded with two strands of tungsten wire (120 m diameter): one anchored in the organ bath chamber (1 ml) and the other connected to a mechanotransducer (model FT-03, Grass). The chamber was perfused at a flow rate of 2.5 ml/min with oxygenated (95% O 2-5% CO2) Krebs-Ringer bicarbonate solution using a peristaltic pump. The composition (in mM) of the Krebs buffer was 118.3 NaCl, 4.7 KCl, 1.2 MgCl2, 1.22 KH2PO4, 2.5 CaCl2, 25.0 NaHCO3, and 11.1 glucose, pH 7.4. Optimal resting tension (0.8-1 g) was applied. Rings were precontracted with 3 M prostaglandin F 2␣ (PGF2␣), and EDR was induced by 3 M acetylcholine (ACh). When EDR had reached a maximum, [K ϩ ]o was increased from 6 to 12 mM in one step or in increments of 2 mM.
Endothelial Cell Culture
Mouse aorta endothelial cells. We isolated endothelial cells from mouse aorta using the "primary explant technique," which is described in detail elsewhere (24, 38) . Cells were grown in growth medium (100 ml) composed of 80 ml of DMEM, 10 ml of fetal calf serum, 7.5 mg of endothelial cell growth supplement (catalog no. E-2759, Sigma), 200 l of heparin (10 U/ml final concentration), 2 ml of penicillin-streptomycin (100 U/ml final concentration), 1 ml of L-glutamine, and 1 ml of minimal essential amino acids. After 4-7 days, the aortic pieces were removed. Cells were passaged as described by Suh et al. (38) Cell culture was maintained at 37°C in a fully humidified 95% air-5% CO 2 atmosphere. The cells were detached by exposure to trypsin, reseeded on gelatin-coated coverslips, and maintained in culture for 2-4 days before use. Measurements were performed on nonconfluent cells.
Electrophysiology
Electrophysiological methods and Ca 2ϩ measurements have been previously described in detail (30) . Membrane potential was monitored in current-clamp mode or controlled in voltage-clamp mode with an EPC-9 (HEKA Elektronik, Lambrecht, Germany) using a nystatin-perforated patch (100 mg/ml). Whole cell currents were measured using ruptured patches. Voltages were monitored in voltage-clamp mode with an EPC-9 (sampling rate 1 ms, 8-pole Bessel filter, 2.9 kHz). The holding potential for the whole cell experiment was 0 or Ϫ60 mV. We applied a voltage ramp from Ϫ100 or Ϫ150 to ϩ100 mV every 10 s with duration of 650 ms. Currents were recorded at a sampling rate of 1-4 kHz.
Ca 2ϩ Measurement
Cells were loaded with fura-2 AM, and [Ca 2ϩ ]i was measured using a microfluorometer consisting of an inverted microscope (DM IRB, Leica, Germany) and a filter scan power illuminator system (Photon Technology International). Fura-2 AM (2 M) was added to the bath, and the cells were incubated for 25 min at 37°C. The cells were illuminated alternatively at wavelengths of 340 and 380 nm through a chopper wheel (frequency ϭ 50 Hz). Fluorescence was measured at 510 nm, and autofluorescence was subtracted from the signals. The free Ca 2ϩ concentration was calculated from the ratio of the fluorescence signals emitted at each excitation wavelength. The calibration procedure was identical to that described previously (30, 31) .
Solutions
The standard external solution contained (in mM) 150 NaCl, 6 KCl, 1.5 CaCl 2, 1 MgCl2, 10 HEPES, and 10 glucose. The osmolarity of the solution, as measured with a vapor pressure osmometer (FISKE), was 320 Ϯ 5 mosM. The standard pipette solution contained (in mM) 40 KCl, 100 potassium-aspartate, 1 MgCl 2, 0.1 EGTA, 4 Na2ATP, and 10 HEPES, with pH adjusted to 7.2 with KOH; osmolarity was 290 mosM.
Chemicals
ATP, ACh, chlorozoxazone (CZ), norepinephrine bitartrate, histamine, ouabain, PGF 2␣, N G -nitro-L-arginine methyl ester (L-NAME), tetraethylammonium chloride (TEA), and zoxazolamine (ZOX) were purchased from Sigma; 1-ethyl-2-benzimidazolinone (1-EBIO) from Tocris, nystatin from ICN Biomedicals, and fura-2 AM from Molecular Probes. 1-EBIO, fura-2 AM, ZOX, and nystatin were applied from a stock solution in DMSO. CZ was applied from a stock solution in methanol. The final concentration of DMSO and methanol was Ͻ0.05%. The mice were treated in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Publication No. 85-23, Revised 1996) and the experimental and animal care protocol was approved by the Animal Care and Use Committee of the Ewha Women's University. All experiments were performed at 37°C. Pooled data are means Ϯ SE, and significant differences were detected using Student's t-test (P Ͻ 0.05).
RESULTS
Effects of Extracellular K ϩ on EDR
Precontracted endothelium-intact aortic rings were relaxed by ACh application (Fig. 1, A1 and B) . In contrast, endothelium-intact aortic rings pretreated with the nitric oxide (NO) synthase inhibitor L-NAME (30 M; Fig. 1A2 ) or endothelium-denuded aortic rings (Fig. 1C) 1A2 ) or in the denuded aorta (Fig. 1C) . These contractions were measured in bicarbonate-buffered solution. In HEPESbuffered solution, K ϩ -induced inhibition of EDR was observed (data not shown).
The K ϩ -induced inhibition of EDR was concentration dependent (Fig. 2) . ACh-evoked relaxation of 84.4 Ϯ 2.0% with 6 mM extracellular K ϩ was reduced to 65. (Fig. 3, A and D) . The same result was observed in voltage-clamped cells (holding potential ϭ 0 mV; Fig. 3, C and E ] i (Fig. 3B) . The K ϩ -induced inhibition of [Ca 2ϩ ] i increase was not dependent on agonists. When endothelial cells were stimulated by ACh (Fig. 3C) or histamine (Fig. 4C) (Fig. 4A) or from 6 to 9 and 12 mM (Fig. 4B) (Fig. 4C) . The K ϩ -induced inhibition was transient, and the duration of its inhibition was concentration dependent (Fig. 4, A and B) (Fig. 5, E-G) . Inasmuch as the increase in [K ϩ ] o from 6 to 12 mM depolarized the resting membrane potential from Ϫ32.8 Ϯ 2.7 to Ϫ8.6 Ϯ 4.9 mV (n ϭ 8) in current-clamped unstimulated EA cells (Fig. 5, C and D ] i from 0.10 Ϯ 0.01 to 0.95 Ϯ 0.03 M, which was significantly decreased to 0.88 Ϯ 0.03 M by the shift of the holding potential to Ϫ25 mV (n ϭ 11, P Ͻ 0.01), and [Ca 2ϩ ] i was further decreased to 0.47 Ϯ 0.04 M by the shift of the holding potential from Ϫ25 to 0 mV (n ϭ 11, P Ͻ 0.001; Fig. 5 , E-G). The decrease in [Ca 2ϩ ] i as a result of depolarization from Ϫ25 to 0 mV was significantly greater than the decrease due to depolarization from Ϫ50 to Ϫ25 mV (n ϭ 11, P Ͻ 0.001). These results suggest that the amount of When MAEC were loaded with 1 M Ca 2ϩ via the patch pipette, an outward current was developed (Fig. 7, A and B) . The Ca 2ϩ -activated current was an intermediate-conductance K ϩ (I K Ca ) current, inasmuch as it was blocked by the I K Ca current blockers charybdotoxin (50 nM) and clotrimazole (10 M; data not shown). The reversal potential of the current obtained by ramp pulses from Ϫ100 to ϩ100 mV was Ϫ70.9 Ϯ 0.1 mV and shifted to Ϫ54.3 Ϯ 0.7 mV when [K ϩ ] o was increased from 6 to 12 mM (n ϭ 3; Fig. 7A ). The increase of [K ϩ ] o decreased K ϩ efflux, especially at negative potentials. On the other hand, TEA decreased the current without changing the reversal potential (Fig. 7B) (Fig. 7C ) and the EDR of mouse aorta (Fig. 7D) . These data suggest that the decrease of K ϩ efflux inhibits the increase in [Ca 2ϩ ] i and, thereby, EDR.
The I K Ca current activators 1-EBIO, CZ, and ZOX reversed K ϩ -induced inhibition of EDR and [Ca 2ϩ ] i increase (Fig. 8) . When the endothelium was removed, the I K Ca current activators did not relax the precontracted aorta (Fig.  8D) . On the other hand, the activators restored the decrease in EDR (Fig. 8, A and B) , and the decrease in [Ca 2ϩ ] i was also restored by the I K Ca current activators in voltageclamped MAEC (Fig. 8C) . These data indicate that the increase of K ϩ efflux by the activators reversed K ϩ -induced inhibition of EDR and [Ca 2ϩ ] i increase. Therefore, we could conclude that K ϩ -induced inhibition might be caused by the decrease of K ϩ efflux. 
An Ouabain-Sensitive Mechanism?
The Na Fig. 9, A and B) , although ouabain itself inhibited EDR concentration dependently (Fig. 9) . In addition, the K ϩ -induced inhibition of [Ca 2ϩ ] i increase was also relieved by ouabain (Fig. 9C) . These results indicate that Na ϩ -K ϩ pump activation is involved in the K ϩ -induced inhibition of EDR and [Ca 2ϩ ] i increase.
DISCUSSION
We report here for the first time that a millimolar increase ] i , which in turn modifies the vascular contractility. Because K ϩ -induced inhibition was observed in at least two kinds of endothelial cells, i.e., MAEC and HUVEC, K ϩ -induced inhibition is likely a general mechanism of endothelium-dependent vasomotor control in different kinds of blood vessels. Therefore, inasmuch as [K ϩ ] o may change by a few millimolars is in various physiological and pathological conditions, we suggest that this mechanism provides a novel controlling signal for vascular contractility.
Inhibitory Mechanisms of Extracellular
Our results suggest that at least three mechanisms are involved in K ϩ -induced inhibition: membrane potentialdependent, K ϩ efflux-dependent, and ouabain-sensitive mechanisms. It is well known that membrane potential affects [Ca 2ϩ ] i by changing the driving force for Ca 2ϩ influx in endothelial cells (19, 20, 44) ] i in endothelial cells and, thereby, inhibit EDR, which is contrary to the previous finding that Na ϩ -K ϩ pump inhibition affected synthesis or release of EDRF(s), rather than its effector pathway (45) . However, because there has been no other report of the effect of Na ϩ -K ϩ pump inhibition or activation on endothelial cells, the role of the Na ϩ -K ϩ pump in EDRF release from endothelial cells is unclear, and the mechanism whereby EDR is inhibited by Na ϩ -K ϩ pump activation requires further evaluation. In contrast, many reports suggested that Na ϩ -K ϩ pump inhibition affected the EDRF effector pathway. Ouabain inhibited sodium nitroprussideinduced relaxation (14, 15, 40) and endothelium-derived hyperpolarizing factor-mediated relaxation (6, 8, 41) . The inhibited relaxation might be caused by the increased contractility of vascular smooth muscle, inasmuch as Na (Fig. 1A-1 and Fig. 8A, arrow) (12) reported that endothelial cell stimulation by ACh raised K ϩ concentration in the myoendothelial space by 5.9 Ϯ 1.0 mM. Although the increase of K ϩ on the luminal side of the endothelium might be less than that in the myoendothelial space because of blood flow, such an increase might be enough to produce K ϩ -induced inhibition, which decreases [Ca 2ϩ ] i . Therefore, we suggest that K ϩ -induced inhibition is a negative-feedback mechanism on [Ca 2ϩ ] i . Through this process, an excessive increase in [Ca 2ϩ ] i might be prevented, and NO release would be appropriately controlled. It is well known that NO is changed to toxic substances such as peroxynitrite by reacting with oxygen radicals (4, 17, 21, 26, 27 
